- Scrip Originals
Brought to you by
Brii Biosciences options up to four Vir programs in China; first project revealed
10 Jun 2020
Brii Biosciences launched and entered into an option agreement with Vir Biotechnology Inc.
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com